Influences of Jujube Witches' Broom (JWB) Phytoplasma Infection and Oxytetracycline Hydrochloride Treatment on the Gene Expression Profiling in Jujube.
Junqiang YangZhongmei ShenPengyan QuRui YangAnping ShaoHao LiAiling ZhaoChunzhen ChengPublished in: International journal of molecular sciences (2023)
Jujube witches' broom disease (JWB), caused by Candidatus Phytoplasma ziziphi , is the most destructive phytoplasma disease threatening the jujube industry. Tetracycline derivatives treatments have been validated to be capable of recovering jujube trees from phytoplasma infection. In this study, we reported that oxytetracycline hydrochloride (OTC-HCl) trunk injection treatment could recover more than 86% of mild JWB-diseased trees. In order to explore the underlying molecular mechanism, comparative transcriptomic analysis of healthy control (C group), JWB-diseased (D group) and OTC-HCl treated JWB-diseased (T group) jujube leaves was performed. In total, 755 differentially expressed genes (DEGs), including 488 in 'C vs. D', 345 in 'D vs. T' and 94 in 'C vs. T', were identified. Gene enrichment analysis revealed that these DEGs were mainly involved in DNA and RNA metabolisms, signaling, photosynthesis, plant hormone metabolism and transduction, primary and secondary metabolisms, their transportations, etc. Notably, most of the DEGs identified in 'C vs. D' displayed adverse change patterns in 'D vs. T', suggesting that the expression of these genes was restored after OTC-HCl treatment. Our study revealed the influences of JWB phytoplasma infection and OTC-HCl treatment on gene expression profiling in jujube and would be helpful for understanding the chemotherapy effects of OTC-HCl on JWB-diseased jujube.
Keyphrases
- genome wide
- genome wide identification
- emergency department
- squamous cell carcinoma
- dna methylation
- poor prognosis
- radiation therapy
- combination therapy
- single molecule
- long non coding rna
- microbial community
- binding protein
- genome wide analysis
- rectal cancer
- circulating tumor
- newly diagnosed
- adverse drug
- aqueous solution